Midgard Science

Labs / Cell line development

MBrace Therapeutics

San Diego, CA, United States · mbracetrx.com

MBrace Therapeutics is a clinical-stage company developing antibody-drug conjugates for cancer. It works on novel target discovery and ADC programs, including MBRC-101 and MBRC-201, for cancer patients. The company is based in San Diego, California, with a research laboratory in North Brunswick, New Jersey.

They take quote requests by email.

What they offer

  • SPARTA antibody selection technology

    Uses in vivo screening to identify antibodies and drug targets for use in ADC development.

  • Novel antibody-target pair discovery

    Identifies antibody and drug target pairs to advance targeted immunotherapies.

  • Antibody development against intracellular targets

    Develops antibodies against intracellular proteins that translocate to the surface of cancer cells.

What they work on

Modalities
Small molecule, Antibody, ADC, Peptide, mRNA, Cell therapy
Assays and studies
in vivo screening, antibody selection
Therapeutic areas
oncology, cancer
Sites
San Diego, USA · North Brunswick, USA
Address
4660 La Jolla Village Dr., Suite 895, San Diego, CA 92122
Founded
2022

Similar labs. Probiocdmo, Sparx BIO, Aurigene Pharmaceutical Services, 3C Therapeutics

Found in a contract services directory. Listing built from mbracetrx.com. Work here? Claim this listing.

MBrace Therapeutics · Midgard Science